ARTIDIS AG is a clinical-stage health-tech start-up founded in Basel, Switzerland, developing the first nanomechanical biomarker for cancer diagnosis and treatment optimization. ARTIDIS seeks to enable professionals to design personalized cancer treatment plans tailored to the individual patient's needs and desired outcomes. The ARTIDISnet platform integrates many different clinical data types, allowing physicians to significantly shorten the current diagnostic process and benefit both the patient and the healthcare system.